Related Experiment Video

Updated: Jun 5, 2026

A Streamlined Approach for Mass Spectrometry-Based Proteomics Using Selected Tissue Regions
09:00

A Streamlined Approach for Mass Spectrometry-Based Proteomics Using Selected Tissue Regions

Published on: April 18, 2025

FAK and interacting proteins as therapeutic targets in pancreatic cancer

Deniz A Ucar1, Steven N Hochwald

  • 1Department of Surgery, University of Florida College of Medicine, Gainesville, 32610, USA.

Anti-Cancer Agents in Medicinal Chemistry
|January 18, 2011
PubMed

Insights

Pancreatic cancer, a leading cause of cancer death, requires new treatments. This review discusses the role of focal adhesion kinase (FAK) in pancreatic cancer and explores FAK inhibitors as a potential therapeutic strategy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Pancreatic cancer is a significant cause of cancer mortality in the US.
  • Current treatments like chemotherapy and radiation offer limited efficacy.
  • Key molecular alterations in pancreatic cancer include genetic mutations (K-ras, p53, p16, DPC4), angiogenic factor upregulation, and dysregulation of kinases like focal adhesion kinase (FAK).

Purpose of the Study:

  • To discuss the role of focal adhesion kinase (FAK) in pancreatic cancer pathogenesis.
  • To review the development of FAK inhibitors for pancreatic cancer treatment.

Main Methods:

  • Literature review of molecular alterations in pancreatic cancer.
  • Analysis of the role of FAK in cancer progression.
  • Review of ongoing research into FAK inhibitors.

Main Results:

  • Focal adhesion kinase (FAK) is implicated in the molecular pathways driving pancreatic cancer.
  • FAK signaling contributes to tumor growth, invasion, and angiogenesis.
  • Development of FAK inhibitors represents a promising therapeutic avenue.

Conclusions:

  • Targeting FAK offers a rational approach to developing novel pancreatic cancer therapies.
  • Further research into FAK inhibitors is crucial for improving patient outcomes.
  • Translating molecular insights into effective clinical strategies is essential for combating pancreatic cancer.

More Related Videos

Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles08:35

Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles

Published on: January 4, 2012

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency07:08

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Published on: February 2, 2024

Related Concept Videos

Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...